medigraphic.com

2007, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2007; 45 (3)

Diagnostic Criteria for Cervicovaginitis and its Congruency with the Mexican Official Norm to Prevent and Control Vaginal Infections

Martínez-Ojeda M, Saldaña-González J, Sánchez-Hernández MA

Language: Spanish
References: 16
Page: 249-254
PDF size: 124.96 Kb.


ABSTRACT

Objective: to analyze currently used criteria to diagnose and treat cervicovaginitis in primary care and its congruency with the Mexican Official Norm (MON).
Methodology: a cross sectional study was conducted to analyze 227 cases with cervicovaginitis. The information was obtained from the clinical charts and the variables were related to the criteria for diagnosis and treatment stated by MON.
Results: the mean age of patients was 31.5 years (SD 7.7). The cervicovaginitis cases were more frequent in the group of 31-35 years of age (21.4 %). The etiology was ascertained in 20.7 %; 48.5 % of clinical charts had registered the clinical information (symptoms and signs); 25.1 % were given specific treatment; in 20.7 % of cases treatment was given to the sexual partner, regardless of the etiology. 24.7 % had registered preventive actions; 10.6 % had gynecological examination; 26.9 % had laboratory exams and 27.3 % of cases were followed up.
Conclusions: little correspondence exists between the MON criteria and the clinical information registered in the clinical charts. This was found in less than thirty percent of cases. The gynecological examination and use of laboratory exams were infrequent, and there were a low percentage of cases in which the etiology was reported and related to the drug treatment.


REFERENCES

  1. Velasco-Murillo V, Pozos-Cavanzos JL, Cardona-Pérez JA. Enfermedades infecciosas del cérvix uterino, vagina y vulva: prevención, diagnóstico y tratamiento. Rev Med IMSS 1999;37(3): 185-191.

  2. Oviedo-Morales MA, Reyes-Morales H, Flores HS, Pérez CR. Fundamentos de las guías clínicas basadas en evidencia. En: Reyes MH, Pérez Cuevas R, Trejo y Pérez JA, editores. Guías de práctica clínica para medicina familiar. México: El Manual Moderno; 2004. p. 9-13.

  3. División Técnica de Información Estadística en Salud. Motivos de consulta en medicina familiar en el IMSS 2002. Rev Med IMSS 2003;41(5):441-448.

  4. Trejo-y Pérez JA, Hernández LB, Carrasco RJR, Ducoing DDLR. Guía clínica para el diagnóstico, tratamiento y prevención de cervicovaginitis por bacterias, tricomonas y candida. En: Reyes-Morales H, Pérez-Cuevas R, Trejo-y Pérez JA, editores. Enfermedades infecciosas. Guías de práctica clínica para medicina familiar. México: El Manual Moderno; 2004. p. 90-93.

  5. Clinical Effectiveness Group de AGUM/MSSVD. Management of T. vaginalis 2001. Disponible en http://www.mssvd.org.uk/PDF/NewCEGS0101/tv0101.PDF

  6. Young GL, Jewell D. Tratamiento tópico para la candidiasis vaginal (muguet) del embarazo (revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, número 3, 2006. Oxford, Update Software Ltd. Disponible en http://www.update-software.com (traducida de The Cochrane Library, 2006 Issue 3. Chichester, UK: John Wiley and Sons, Ltd).

  7. Flores RGA, Alvarado G, Guerrero GC. Enfermedades infecciosas cervicovaginales en mujeres de edad reproductiva en el Hospital Universitario de Puebla durante 2001, XXVII Congreso Anual de la AMIMC, 2002.

  8. Mendoza GA, Sánchez VJT, Sánchez PI, Ruiz SD, Tay ZJ. Frecuencia de vaginosis producida por Gardnerella vaginalis y su asociación con otros patógenos causantes de infección genital en la mujer. Ginecol Obstet Mex 2001;69(7):272-276.

  9. Martínez TMA, Barria A, Meneses R, et al, Vulvovaginitis en la adolescencia: estudio etiológico. Rev Chil Obstet Ginecol 2003;68(6): 499-502.

  10. Flores PR, Rivera SR, García-Jiménez E, Arriaga-Alba M. Etiología de la infección cervicovaginal en pacientes del Hospital Juárez de México. Salud Publica Mex 2003;45(5):s694-s697.

  11. Casanova RG, Narcio RLE, Ortiz IJ, Beltrán ZM, Castelo ME. Utilidad del examen en fresco para el diagnóstico de candidiasis. Ginecol Obstet Mex 1997;65:87-92.

  12. Calzolari E, Masciangelo R, Melite V, Verteramo R. Bacterial vaginosis and contraceptive methods. Int J Gynecol Obstet 2000;70:341-346.

  13. Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 2001;91(10):1664-1670.

  14. Beltrán MJ, Ávila VMA, Valdillo OF, Hernández GC, Peraza GF, Olivares MS. Infección cervicovaginal como factor de riesgo para parto pretérmino. Ginecol Obstet Mex 2002; 70(4):203-209.

  15. Flores-Paz, Rivera-Sánchez R, García J, Arriaga M. Etiología de la infección cervicovaginal. México: Salud Publica Mex 2003;45(Supl 5): S694-S697.

  16. Secretaría de Salud. Proyecto de Norma Oficial Mexicana, para la prevención y control de las infecciones de transmisión sexual. PROY-NOM-039-SSA2-2000. Disponible en http://www.salud.gob.mx/conasida/eventos/nom-sida/its.pdf




2020     |     www.medigraphic.com